demonstrated right sided firmness in the mid and apical regions with the suggestion of extraprostatic cancer (cT3a) at the mid gland posteriorly. Transrectal ultrasound-guided prostate biopsy ...

An enzyme called EZH2 has an unexpected role in driving aggressive tumor growth in treatment-resistant prostate cancers, according to a new study by scientists at Weill Cornell Medicine.